ChAbS Reaches 20,000 LinkedIn Followers!

We’re thrilled to announce that ChAbS LinkedIn page has officially surpassed 20,000 followers!

This milestone reflects the growing global community that shares our mission — to connect industry, academia, and investment and advance innovation in antibody therapeutics.

A heartfelt thank you to all our members, partners, and supporters for being part of this journey. Your engagement inspires us to keep building a stronger platform for collaboration and knowledge exchange.

Follow us on LinkedIn for the latest updates: ChAbS